Monopar Therapeutics (MNPR) said Wednesday it closed its best efforts public offering of common shares at $16.25 per share for total gross proceeds of about $19.2 million.
The company said it plans to use proceeds for general corporate purposes.
Monopar Therapeutics shares were down more than 6% in recent trading.
Price: 15.19, Change: -1.02, Percent Change: -6.29